HTID#5 Program

Tuesday, October 24th 2023

08:40am - 09:10am

09:10am - 10:20am

10:25am - 11:10am

11:25am - 12:10pm

Opening Ceremony

• Maryvonne HIANCE, President, HealthTech For Care
• Pierre COURTEILLE, CBO, Abivax
• Olivier BECHT, Minister Delegate for Foreign Trade, Economic Attractiveness, and French Nationals abroad.
• Shlomi KOFMAN, Vice President International Operations, Israel's Innovation Authority

12:15pm - 12:35pm

Introducing : European fund for digital sovereignty

• Alain GODARD, Chairman and Managing Director, European Fund for Digital Sovereignty, the "European Tech Champions Initiative"

12:35pm - 01:30pm

01:30pm - 02:15pm

How macro-economic forces are shaping European healthcare innovation

• Christian PIERRET, French Former Minister of Industry (moderator)
• Dr. Dana BURDUJA, Head of Life Sciences and Health division, European Investment Bank
• Olga SOLOMON, Acting Director DPT, Medical Products and Innovation, DG Santé-European commission
• Bernard SPITZ, Chairman and Founder, BSC (Strategic Advisory)

02:20pm - 02:35pm

Crossed views: Supporting the growth of HealthTech companies to enhance innovation to the benefit of patients

• Suyin AERTS, Host event
• Guillaume MORELLI, Head of Listing France, Spain & Portugal, Euronext
• Gilles AVENARD, CEO, Acticor Biotech

02:40pm - 03:25pm

Innovative new licensing and M&A deals in healthtech

• Anne-France MOREAU, Life Sciences Partner, McDermott Will & Emery (moderator)
• Iordanis ARZIMANOGLOU, Programme Manager for Health and Biotechnology, European Innovation Council, European Commission
• Elena COLLUCCELLI-GUERIN, Managing Partner, Healthcare M&A, focus on mid cap, Rothschild & Co
• Antoine KHALLOUF, Director - Healthcare Group, Rothschild&Co
• Nicolas POIRIER, Chief Executive Officer & Chief Scientific Officer, OSE Immunotherapeutics
• Hubert CHAPERON, Chief Strategy Officer, Owkin

03:40pm - 04:15pm

From prevention to treatments together with patients

• Anaïs LE CORVEC, Co-Founder, Cliclab Transformative Agent (moderator)
• Alain HERRERA, Oncologist & Hematologist (moderator)
• Mia BAJRAMAGIC, IDF Europe Project Coordinator, Physician, Patient Advocate and a person living with Type one Diabetes
• Cristina NICULESCU, Senior Lifescience Specialist, European Investment Bank
• Meritxell TEIXIDO, CEO and Co-founder, Gate2Brain

04:20pm - 04:50pm

Virtual universe in healthtech, what does it bring to patients?

• Gabriela APIOU, Massachusetts General Hospital, Harvard Medical School (moderator)
• Alon WOLF, Technion Israel Institute of Technology
• Anca PETRE, Medrise Studio
• David BINDER, Massachusetts General Hospital, Harvard Medical School
• Myriam BEAVES, Dassault Systèmes

05:05pm - 05:50pm

Making the EU a more attractive playground now and for the future

• Stephanie LEOUZON, Managing Director, Stifel’s Global Healthcare Group (moderator)
• Siham IMANI, Executive Vice President Corporate Strategy & Business Development, Servier
• Rainer Westermann, chairman, Life Sciences Acceleration Alliance
• Cédric MOREAU, Partner, Sofinnova Partners

05:55pm - 07:05pm

07:05pm - 08:35pm

Wednesday, October 25th 2023

07:30am - 08:00am

08:00am - 09:00am

09:10am - 09:50am

Can biotechs succeed outside Boston?

• Philippe LOPES-FERNANDES, Executive Vice President, Chief Business Officer, Ipsen
• Pascal PRIGENT, Chief Executive Officer, GENFIT
• Lise ALTER, General Director, Agence Innovation Santé
• Rodolphe Clerval, Chief Executive Officer, Coave Tx

09:55am - 10:30am

Unlocking opportunities in Asia for European healthtech companies

• Marc DECHAMPS, CEO, Bioxodes (moderator)
• Eric HALIOUA, CEO, PDC*Line Pharma
• Fleur PELLERIN, Founded Partner, Korelya Capital
• Eric DE LA FORTELLE, Managing Partner, Cathay Health
• Philippe DE BACKER, Senior Partner, Newton BioCapital

10:45am - 11:45pm

11:50am - 12:05pm

Introducing : HERA missions (Health Emergency Preparedness and Response Authority)

• Olivier GIRARD, Head of Unit, Medical Counter-Measures, European Commission

12:10pm - 12:25pm

Introducing : European health position

• Audrey DERVELOY, President & Country Lead, Sanofi France

12:25pm - 01:25pm

01:25pm - 01:40pm

Introducing : Translating science into survival, reporting on the evolution of the immunotherapy hub

• Christoph HUBER, Professor emeritus hematology-oncology Johannes-Gutenberg-University, co-founder BioNTech SE and TRON GmbH

01:45pm - 02:30pm

Oncology : new tools to optimize therapeutic solution development from discovery to lifecycle management

• Thierry ANDRE, Medical Oncologist, PU-PH, chef de service, Hôpital Saint Antoine, APHP (moderator)
• Marc BUYSE, Chief Scientific Officer, IDDI and CluePoints
• Samer EL BAWAB, Global Head of Quantitative Pharmacology, Servier
• Cyril SARRAUSTE DE MENTHIERE, Partner Patient, co-manager of MRCCR, subsidiary of « Patients en réseau » association
• Federico GOODSAID, SVP Regulatory Affairs at Ariana Pharma

02:35pm - 03:15pm

Non violent therapies : Toposteric effect

• Max HERZBERG, Chairman, Vidac Pharma (moderator)
• Wolfgang LINK, Spanish National Research Council (CSIC), Institute of Biomedical Research Alberto Sols (IIBM)
• Laetitia LINARES, PhD MetaSarc, Metabolism and sarcoma IRCM, Institut de Recherche en Cancérologie de Montpellier INSERM U1194
• Lyora AHARONOV, co-founder and CEO, EMRIS Pharma

03:20pm - 03:55pm

Metabolic diseases: trends and funding issues-innovation

• Kyle J. ROSE, Vice President International Diabetes Federation (moderator)
• Benjamin CHARLES, CEO, DiogenX
• Laurent-Dominique PIVETEAU, CEO, Debiotech
• Philippe ROCOLLE, Director Center of Excellence Digital Health General Medicine France, Sanofi
• Craig COOPER, Investor, Advisor, Board Member, Serpentine Ventures

04:10pm - 04:45pm

Entrepreneurs’ strategies for success when navigating through rough waters

• Pierre COURTEILLE, CBO, Abivax (moderator)
• Benoit VAN DEN HOVE, CEO Euronext Brussels
• Enrique CLAVEROL-TINTURE, Head of the Medical Technologies Programme, European Innovation Council, European Commission
• Olivier TAELMAN, CEO, Nyxoah

04:50pm- 05:30pm

Strengthening diversity among all stakeholders: an opportunity and an imperative

• Anais LE CORVEC, Co-Founder, Cliclab Transformative Agent
• Beatrice CHEMLA, CEO & Co-founder, IMMA.Health
• Jenny YIP, Managing Partner, Adjuvant Capital
• Elisabeth DEL VALLE, Co-founder & CEO, Onalabs
• Jessica MATOUA-DAVID, Co-founder, Nemow group think tank

05:40pm - 06:00pm

Pitch Award

• Bernard HINAULT, five time Tour de France Winner and Association Cardiac des Monts ambassador
• Jean Phillipe VERHOYE, MD,PhD Chief department of Thoracic and cardiovascular Surgery Co-Director of INSERM Unit U1099 LTSI University Hospital Rennes1

06:05pm - 07:20pm